GEMINI THERAPEUTICS INC (GMTX) Forecast, Price Target & Analyst Ratings

NASDAQ:GMTX • US36870G1058

Current stock price

1.35 USD
0 (0%)
At close:
1.32 USD
-0.03 (-2.22%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GEMINI THERAPEUTICS INC (GMTX).

Forecast Snapshot

Consensus Price Target

Price Target
$1.53
+ 13.33% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 8, 2023
Period
Q4 / 2022
EPS Estimate
-$0.20
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.53
Upside
+ 13.33%
From current price of $1.35 to mean target of $1.53, Based on 6 analyst forecasts
Low
$1.52
Median
$1.53
High
$1.58

Price Target Revisions

1 Month
0.00%
3 Months
N/A

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for GMTX. The average price target is 1.53 USD. This implies a price increase of 13.33% is expected in the next year compared to the current price of 1.35.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GMTX Current Analyst RatingGMTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

GMTX Historical Analyst RatingsGMTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
GMTX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about GMTX.
In the previous month the buy percentage consensus was at a similar level.
GMTX was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-03-11HC Wainwright & Co.Downgrade Buy -> Neutral
2022-03-03SVB LeerinkDowngrade Outperform -> Market Perform
2022-03-01JefferiesDowngrade Buy -> Hold
2022-01-24SVB LeerinkMaintains Outperform
2021-12-20SVB LeerinkMaintains Outperform
2021-12-15HC Wainwright & Co.Initiate Buy
2021-10-06Goldman SachsMaintains Buy
2021-04-08SVB LeerinkInitiate Outperform
2021-03-03JefferiesInitiate Buy
2021-03-02Goldman SachsInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 8, 2023
Period
Q4 / 2022
EPS Estimate
-$0.20
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
50.24%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A

Next Earnings Summary

GMTX is expected to report earnings on 3/8/2023. The consensus EPS estimate for the next earnings is -0.2 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
GMTX revenue by date.GMTX revenue by date.
N/AN/AN/AN/AN/A
EBITDA
YoY % growth
GMTX ebitda by date.GMTX ebitda by date.
N/AN/A-68.471M
-55.78%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
GMTX ebit by date.GMTX ebit by date.
-810K-68.702M
-8,381.73%		N/A
64.92%		N/A
-19.04%		N/A
-20.43%		N/A
21.31%		N/A
19.74%
Operating Margin
GMTX operating margin by date.GMTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
GMTX eps by date.GMTX eps by date.
N/AN/A-1.81
67.85%		N/A
81.97%		N/A
18.75%		N/A
7.69%		N/A
-11.00%		N/A
-13.22%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 22
EPS
Q2Q % growth		-0.20
50.24%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-8.659M
51.20%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GMTX Yearly EPS VS EstimatesGMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3 -4 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.09%
EPS Next 5 Year
12.85%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

GEMINI THERAPEUTICS INC / GMTX Forecast FAQ

What is the average price target for GEMINI THERAPEUTICS INC (GMTX) stock?

6 analysts have analysed GMTX and the average price target is 1.53 USD. This implies a price increase of 13.33% is expected in the next year compared to the current price of 1.35.

When does GEMINI THERAPEUTICS INC (GMTX) report earnings?

GEMINI THERAPEUTICS INC (GMTX) will report earnings on 2023-03-08.

What are the consensus estimates for GEMINI THERAPEUTICS INC (GMTX) next earnings?

The consensus EPS estimate for the next earnings of GEMINI THERAPEUTICS INC (GMTX) is -0.2 USD and the consensus revenue estimate is 0 USD.

How many analysts cover GEMINI THERAPEUTICS INC (GMTX) stock?

The number of analysts covering GEMINI THERAPEUTICS INC (GMTX) is 6.